Lessons learned from human HIV vaccine trials

PURPOSE OF REVIEW: The ability to induce broadly neutralizing antibody (bNAb) responses is likely essential for development of a globally effective HIV vaccine. Unfortunately, human vaccine trials conducted to date have failed to elicit broad plasma neutralization of primary virus isolates. Despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Pollara, Justin, Easterhoff, David, Fouda, Genevieve G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
HIV AND NOVEL STRATEGIES FOR INDUCTION OF BROAD NEUTRALIZING ANTIBODIES FOLLOWING VACCINATION: Edited by Ralf Wagner
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389590/
https://www.ncbi.nlm.nih.gov/pubmed/28230655
http://dx.doi.org/10.1097/COH.0000000000000362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389590/
https://www.ncbi.nlm.nih.gov/pubmed/28230655
http://dx.doi.org/10.1097/COH.0000000000000362

Ejemplares similares